SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
FRA:SHL - Deutsche Boerse Ag - DE000SHL1006 - Common Stock - Currency: EUR
SHL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SHL while its profitability can be described as average. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
SHL had a positive operating cash flow in the past year.
SHL had positive earnings in each of the past 5 years.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
SHL has a Return On Assets of 4.11%. This is in the better half of the industry: SHL outperforms 67.92% of its industry peers.
SHL's Return On Equity of 10.04% is fine compared to the rest of the industry. SHL outperforms 75.47% of its industry peers.
With a decent Return On Invested Capital value of 6.21%, SHL is doing good in the industry, outperforming 69.81% of the companies in the same industry.
SHL had an Average Return On Invested Capital over the past 3 years of 5.87%. This is below the industry average of 8.33%.
The 3 year average ROIC (5.87%) for SHL is below the current ROIC(6.21%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.11% | ||
| ROE | 10.04% | ||
| ROIC | 6.21% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
SHL has a better Profit Margin (8.76%) than 64.15% of its industry peers.
SHL's Profit Margin has declined in the last couple of years.
SHL has a Operating Margin of 12.85%. This is in the better half of the industry: SHL outperforms 67.92% of its industry peers.
SHL's Operating Margin has declined in the last couple of years.
SHL has a worse Gross Margin (38.18%) than 71.70% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.85% | ||
| PM (TTM) | 8.76% | ||
| GM | 38.18% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
SHL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
The debt/assets ratio for SHL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 1.91 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHL has a Altman-Z score of 1.91. This is comparable to the rest of the industry: SHL outperforms 56.60% of its industry peers.
The Debt to FCF ratio of SHL is 6.15, which is on the high side as it means it would take SHL, 6.15 years of fcf income to pay off all of its debts.
SHL's Debt to FCF ratio of 6.15 is fine compared to the rest of the industry. SHL outperforms 66.04% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that SHL is somewhat dependend on debt financing.
SHL has a Debt to Equity ratio of 0.71. This is in the lower half of the industry: SHL underperforms 69.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 6.15 | ||
| Altman-Z | 1.91 |
ROIC/WACC1.03
WACC6.04%
2.3 Liquidity
SHL has a Current Ratio of 1.28. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL's Current ratio of 1.28 is in line compared to the rest of the industry. SHL outperforms 41.51% of its industry peers.
A Quick Ratio of 0.89 indicates that SHL may have some problems paying its short term obligations.
The Quick ratio of SHL (0.89) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 10.84% over the past year.
Measured over the past 5 years, SHL shows a small growth in Earnings Per Share. The EPS has been growing by 7.27% on average per year.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 4.09% in the last year.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)10.84%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%4.08%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%5.91%
3.2 Future
Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.77% on average per year.
The Revenue is expected to grow by 5.26% on average over the next years.
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y9.77%
Revenue Next Year5.94%
Revenue Next 2Y6.14%
Revenue Next 3Y6.36%
Revenue Next 5Y5.26%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.82, SHL is valued on the expensive side.
Based on the Price/Earnings ratio, SHL is valued a bit cheaper than the industry average as 79.25% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.79, SHL is valued a bit cheaper.
With a Price/Forward Earnings ratio of 16.42, SHL is valued correctly.
Based on the Price/Forward Earnings ratio, SHL is valued a bit cheaper than 71.70% of the companies in the same industry.
SHL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.82 | ||
| Fwd PE | 16.42 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than the industry average as 75.47% of the companies are valued more expensively.
88.68% of the companies in the same industry are more expensive than SHL, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.55 | ||
| EV/EBITDA | 15.7 |
4.3 Compensation for Growth
SHL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SHL's earnings are expected to grow with 12.78% in the coming years.
PEG (NY)1.71
PEG (5Y)2.86
EPS Next 2Y13.11%
EPS Next 3Y12.78%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.13%. Purely for dividend investing, there may be better candidates out there.
SHL's Dividend Yield is rather good when compared to the industry average which is at 2.45. SHL pays more dividend than 83.02% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.51, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.13% |
5.2 History
On average, the dividend of SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr Years2
Div Non Decr Years5
5.3 Sustainability
SHL pays out 53.55% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP53.55%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
FRA:SHL (4/25/2025, 7:00:00 PM)
46.84
+0.96 (+2.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.28%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap52.84B
Analysts82.96
Price Target64.27 (37.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.13% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP53.55%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.98%
Min EPS beat(2)3.67%
Max EPS beat(2)8.28%
EPS beat(4)3
Avg EPS beat(4)4.22%
Min EPS beat(4)-0.13%
Max EPS beat(4)8.28%
EPS beat(8)5
Avg EPS beat(8)2.12%
EPS beat(12)8
Avg EPS beat(12)2.61%
EPS beat(16)10
Avg EPS beat(16)3.31%
Revenue beat(2)1
Avg Revenue beat(2)0.24%
Min Revenue beat(2)-0.81%
Max Revenue beat(2)1.29%
Revenue beat(4)1
Avg Revenue beat(4)-1%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.15%
Revenue beat(16)8
Avg Revenue beat(16)0.73%
PT rev (1m)0.99%
PT rev (3m)7.04%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)0.98%
EPS NY rev (1m)-0.33%
EPS NY rev (3m)-1.84%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)1.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.82 | ||
| Fwd PE | 16.42 | ||
| P/S | 2.33 | ||
| P/FCF | 19.55 | ||
| P/OCF | 15.38 | ||
| P/B | 2.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.7 |
EPS(TTM)2.25
EY4.8%
EPS(NY)2.85
Fwd EY6.09%
FCF(TTM)2.4
FCFY5.11%
OCF(TTM)3.05
OCFY6.5%
SpS20.1
BVpS17.53
TBVpS-5.4
PEG (NY)1.71
PEG (5Y)2.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.11% | ||
| ROE | 10.04% | ||
| ROCE | 7.92% | ||
| ROIC | 6.21% | ||
| ROICexc | 6.76% | ||
| ROICexgc | 28.88% | ||
| OM | 12.85% | ||
| PM (TTM) | 8.76% | ||
| GM | 38.18% | ||
| FCFM | 11.92% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score6
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 6.15 | ||
| Debt/EBITDA | 3.39 | ||
| Cap/Depr | 59.34% | ||
| Cap/Sales | 3.24% | ||
| Interest Coverage | 8.67 | ||
| Cash Conversion | 82.8% | ||
| Profit Quality | 136.12% | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 1.91 |
F-Score6
WACC6.04%
ROIC/WACC1.03
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)10.84%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%4.08%
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y9.77%
Revenue 1Y (TTM)4.09%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%5.91%
Revenue Next Year5.94%
Revenue Next 2Y6.14%
Revenue Next 3Y6.36%
Revenue Next 5Y5.26%
EBIT growth 1Y31.99%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year53.67%
EBIT Next 3Y23.22%
EBIT Next 5Y15.57%
FCF growth 1Y165.16%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y80.08%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%